He encontrado que alguna farmacia puede tener existencias limitadas de ciertos medicamentos, mientras que otras pueden tener casi cualquier formato que se le ocurra y el habitual de dosis habitualidad apareció. En resumen, siempre se contiene el almacén de corroborar. Al mismo tiempo que el producto que más que gustaba ha resultado no estaba disponible en stock otro distinto por las Buenas costumbres también debe buscarse jefe no asн parezca. Por eso es importante disponer de un Plan B para actuar cuandod ello no ocurra.
Ventaja de tomar un genérico en lugar de Asix
Un genérico es más barato que el nombre de marca
Uno de los mayores incentivos para someterse al Dónde comprar Lasix genérico en lugar de pagar la marca es que usted puede obtener un ahorrando importantes Lasix genérico. Por lo tanto, un Lasix genérico es en general mucho más barato que el homólogo de marca, así que una denominación genérica se hace posible para las personas que usan este medicamento con frecuencia. Un ejemplo: La compra de lurosemida en lugar de Lasix es una considerable ahorro para el presupuesto mensual de medicamentos.
Uob.com.sg
United International Growth Fund Funds Review Fund Objective Fund Details
The Fund aims to achieve long-term capital appreciation through investing mainly in shares in global LAUNCH DATE
emerging and developed markets, identified by the Managers as having good prospects for growth. March 1995 FUND SIZE S$174.25 million NAV PRICE (as at 30 Sep 08) SUBSCRIPTION Top 10 Holdings (As at 30 Sep 2008) Asset Allocation (As at 30 Sep 2008) Cash, CPF-OA & SRS INITIAL INVESTMENT By Country SUB INVESTMENT MANAGEMENT FEE 1.00% p.a. SUBSCRIPTION FEE 5% (Cash,SRS) 3% (CPF-OA) MINIMUM RSP By Sector S$100/month, S$500/quarter HSBC Institutional Trust
Performance
7th April 95 To 30th September 08, Performance Based in
-11.15% -15.59% -11.54% Fund Awards
-14.41% -18.69% -14.85% Fund Awards 03, 06
-26.60% -30.27% -29.57% SG S&P Inv. Funds Awards
Source: Lipper • Performance as at 30 Sep 08, SGD basis, with dividends and distributions reinvested, if any. • Performance figures for 1 mth till 1 yr show the % change, while those
*The above chart reflects performance from the first
exceeding 1 yr show the average annual
month end of the Fund. ^5% sales charge applied. compounded return. Contact Details
Benchmark (BM) : Apr 95 - Dec 96 : DBS 50 Index; Jan 97 - Dec 97 : MSCI AC Far East; Jan 98 -
Hotline (24-hour): Website: uobam.com.sg IMPORTANT NOTICE AND DISCLAIMERS
A prospectus for the fund(s) (the "Fund(s)") may be obtained from the Manager or any of its appointed distributors. Investors
should read the prospectus before deciding whether to subscribe for or purchase units in the Fund(s) ("Units"). All applications
for Units must be made on application forms accompanying the prospectus or otherwise as described in the prospectus.
Past performance of the Fund(s) or the Manager and any forecasts on the economy or markets are not indicative of the future or likely performance of the Fund(s) or the Manager. Any extraordinary performance may be due to exceptional
circumstances which may not be sustainable. The value of Units and any income from the Fund(s) may fall as well as rise.
The above information is strictly for information purposes only and must not be construed as an offer or solicitation to deal
in Units, nor a recommendation to invest in any company mentioned herein. Investments in unit trusts are not obligations of,
deposits in, or guaranteed or insured by UOB, UOBAM, or any affiliates or distributors. An investment in unit trusts is subject
to investment risks and foreign exchange risks, including the possible loss of the principal amount invested. Investors may
wish to seek advice from a financial adviser before making a commitment to invest in Units. In the event an investor chooses
not to seek advice from a financial adviser, the investor should consider whether the Fund(s) in question is/are suitable for him.
UOB Asset Management Ltd Co. Reg. No.: 198600120Z
REGULAR PAPER A HISTOMORPHOMETRICAL STUDY OF THE EFFECTS OF ETHANOL ON ENAMEL FORMATION IN RAT MANDIBULAR MOLARS DURING PREGNANCY Luciana Barros Sant’Anna and Darcy de Oliveira ToselloDepartment of Morphology, Faculty of Odontology, State University of Campinas (UNICAMP), Piracicaba, SP, Brazil. ABSTRACT The consumption of alcohol during pregnancy causes fetal congenital malformat
For Release December 2010 Blue Cross and Blue Shield of Alabama’s Pharmacy and Therapeutics (P & T) Committee recently approved updates to the Prescription Drug Guide and made clinical program changes to select medications. All information is accessible online at www.bcbsal.com .The P & T Committee consisting of doctors, pharmacists, nurses, and other healthcare pro